Science Advances · 2022 · 20 citations · 52 references
MedicineCancer BiologyMolecular GeneticsCancer GeneticsMolecular NeuroscienceNeuro-oncologyAstrocyte BiologyBrain TumorsCancer Cell SignalingGlial Cell BiologyPediatric Brain TumorsPediatric Cancer BiologyAstrocyte GeneticsAstrocyte HeterogeneityAstrocyte TranscriptomicsAstrocytoma PathologyGlial Tumor GeneticsMedulloblastoma PathologyMolecular RelapsePediatric Brain Tumor Biology
SRY (sex determining region Y)–box 2 (SOX2)–labeled cells play key roles in chemoresistance and tumor relapse; thus, it is critical to elucidate the mechanisms propagating them. Single-cell transcriptomic analyses of the most common malignant pediatric brain tumor, medulloblastoma (MB), revealed the existence of astrocytic Sox2 + cells expressing sonic hedgehog (SHH) signaling biomarkers. Treatment with vismodegib, an SHH inhibitor that acts on Smoothened (Smo), led to increases in astrocyte-like Sox2 + cells. Using SOX2-enriched MB cultures, we observed that SOX2 + cells required SHH signaling to propagate, and unlike in the proliferative tumor bulk, the SHH pathway was activated in these cells downstream of Smo in an MYC-dependent manner. Functionally different GLI inhibitors depleted vismodegib-resistant SOX2 + cells from MB tissues, reduced their ability to further engraft in vivo, and increased symptom-free survival. Our results emphasize the promise of therapies targeting GLI to deplete SOX2 + cells and provide stable tumor remission.
52
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott, Andrey Korshunov, Hendrik Witt et al. · Journal of Clinical Oncology · 2010 · 1.4K citations · Full text
Medicine, Cancer Biology, Oncology +17
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M.G. Cavalli, Marc Remke, Ladislav Rampášek et al. · Cancer Cell · 2017 · 1.3K citations · Full text
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
Charles M. Rudin, Christine L. Hann, John Laterra et al. · New England Journal of Medicine · 2009 · 1K citations · Full text
Medicine, Oncology, Pharmacology +17